Contrasting Mettler-Toledo International (NYSE:MTD) and Nautilus Biotechnology (NASDAQ:NAUT)
Contrasting Mettler-Toledo International (NYSE:MTD) and Nautilus Biotechnology (NASDAQ:NAUT)
Mettler-Toledo International (NYSE:MTD – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.
梅特勒-托莱多国际(NYSE：MTD-GET Rating)和鹦鹉螺生物科技(Nautilus Biotech)(纳斯达克：NAUT-GET Rating)都是计算机和科技公司，但哪项业务更优越？我们将根据两家公司的盈利能力、股息、收益、风险、分析师建议、估值和机构持股的强项对两家公司进行比较。
Institutional and Insider Ownership
机构和内部人持股
91.9% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 45.3% of Nautilus Biotechnology shares are owned by institutional investors. 2.8% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 41.3% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
梅特勒-托莱多国际公司91.9%的股份由机构投资者持有。相比之下，机构投资者持有鹦鹉螺生物技术公司45.3%的股份。梅特勒-托莱多国际公司2.8%的股份由公司内部人士持有。相比之下，鹦鹉螺生物技术公司41.3%的股份由公司内部人士持有。强大的机构持股表明，大型基金管理公司、捐赠基金和对冲基金相信，一家公司有望实现长期增长。
Profitability
盈利能力
This table compares Mettler-Toledo International and Nautilus Biotechnology's net margins, return on equity and return on assets.
该表比较了梅特勒-托莱多国际公司和鹦鹉螺生物技术公司的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.48% | 1,929.28% | 26.15% |
| Nautilus Biotechnology | N/A | -17.79% | -16.17% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 梅特勒-托莱多国际 | 21.48% | 1,929.28% | 26.15% |
| 鹦鹉螺生物技术 | 不适用 | -17.79% | -16.17% |
Analyst Ratings
分析师评级
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 4 | 2 | 0 | 2.33 |
| Nautilus Biotechnology | 0 | 2 | 0 | 0 | 2.00 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 梅特勒-托莱多国际 | 0 | 4 | 2 | 0 | 2.33 |
| 鹦鹉螺生物技术 | 0 | 2 | 0 | 0 | 2.00 |
Mettler-Toledo International currently has a consensus price target of $1,356.00, indicating a potential downside of 6.19%. Nautilus Biotechnology has a consensus price target of $4.00, indicating a potential upside of 122.22%. Given Nautilus Biotechnology's higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Mettler-Toledo International.
梅特勒-托莱多国际公司目前的普遍目标价为1,356.00美元，这意味着潜在的下行幅度为6.19%。鹦鹉螺生物技术公司的共识目标价为4.00美元，表明潜在上涨122.22。鉴于鹦鹉螺生物技术的上行可能性更高，分析师显然认为鹦鹉螺生物技术公司比梅特勒-托莱多国际公司更有利。
Valuation and Earnings
估值和收益
This table compares Mettler-Toledo International and Nautilus Biotechnology's revenue, earnings per share (EPS) and valuation.
该表格比较了梅特勒-托莱多国际公司和鹦鹉螺生物科技公司的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $3.72 billion | 8.67 | $768.98 million | $36.54 | 39.56 |
| Nautilus Biotechnology | N/A | N/A | -$50.31 million | ($0.49) | -3.67 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 梅特勒-托莱多国际 | 37.2亿美元 | 8.67 | 7.6898亿美元 | $36.54 | 39.56 |
| 鹦鹉螺生物技术 | 不适用 | 不适用 | -5,031万元 | ($0.49) | -3.67 |
Mettler-Toledo International has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
梅特勒-托莱多国际公司的收入和收益高于鹦鹉螺生物科技公司。鹦鹉螺生物科技的市盈率低于梅特勒-托莱多国际，表明它目前是两只股票中更负担得起的一只。
Risk & Volatility
风险与波动性
Mettler-Toledo International has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
梅特勒-托莱多国际的贝塔系数为1.21，这表明其股价的波动性比标准普尔500指数高出21%。相比之下，鹦鹉螺生物技术公司的贝塔系数为0.84，这表明其股价的波动性比标准普尔500指数低16%。
Summary
摘要
Mettler-Toledo International beats Nautilus Biotechnology on 11 of the 13 factors compared between the two stocks.
梅特勒-托莱多国际公司在比较两只股票的13个因素中有11个击败了鹦鹉螺生物科技公司。
About Mettler-Toledo International
关于梅特勒-托莱多国际公司
(Get Rating)
(获取评级)
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
梅特勒-托莱多国际公司致力于在全球范围内制造和供应精密仪器和服务。它分为五个部门：美国业务、瑞士业务、西欧业务、中国业务和其他业务。该公司的实验室仪器包括实验室天平、液体移液、自动化实验室反应器、滴定仪、pH计、过程分析传感器和分析技术、物理值分析仪、热分析系统和其他分析仪器；以及LABX，这是一个管理和分析其仪器产生的数据的实验室软件平台。其工业仪器包括工业称重仪器及相关终端、自动尺寸测量和数据采集解决方案、车辆称重系统、工业软件、金属检测、X射线、校核称重、基于相机的成像设备、跟踪和跟踪解决方案以及产品检测系统。该公司的零售称重解决方案包括联网称重和软件、独立称重以及用于处理新鲜商品的自动化包装和标签解决方案。它通过其直销队伍和间接分销渠道，为生命科学行业、独立研究机构和检测实验室、食品和饮料制造商、食品零售商、化学、特种化学品和化妆品公司、食品零售商、运输和物流、金属和电子行业以及学术界提供服务。该公司成立于1991年，总部设在俄亥俄州哥伦布市。
About Nautilus Biotechnology
关于鹦鹉螺生物技术
(Get Rating)
(获取评级)
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
鹦鹉螺生物技术公司是一家处于发展阶段的生命科学公司，致力于创建一种量化和解锁蛋白质组复杂性的平台技术。它开发了Nautilus Platform，这是一个蛋白质组学平台，包括由仪器、消耗品和软件分析组成的端到端解决方案。该公司成立于2016年，总部位于华盛顿州西雅图。
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
接受梅特勒-托莱多国际日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对梅特勒-托莱多国际公司和相关公司的最新新闻和分析师评级的每日简要摘要。